Encoded where nobody was looking
Mitochondria carry their own small genome, long assumed to code only for components of the respiratory machinery. MOTS-c was identified in a reading frame within the 12S ribosomal RNA region, which was not thought to encode anything of the sort.
That places it in a small class of mitochondrial-derived peptides. The implication is that the mitochondrion signals to the rest of the cell in its own right rather than only responding, which was a genuine shift in how the organelle is understood.
There is a wrinkle in how the region is read. Mitochondria use a genetic code that departs from the nuclear one at a handful of codons, so a reading frame in that genome has to be interpreted under mitochondrial rules rather than the familiar ones. That quirk is part of why the coding potential sat unnoticed for as long as it did.
Metabolic signalling and the exercise link
Research has focused on metabolic regulation, with reported involvement in glucose handling and in pathways associated with energy stress. Some work links circulating levels to exercise, which is why the compound turns up in performance discussions.
Most of that work is cell culture and animal models. The findings are interesting and reasonably coherent, and they are also early. Human data is thin.
A search for what is mots-c returns a striking amount of confident writing for a compound this early in its investigation. The papers indexed on PubMed form a smaller and markedly more careful body of work than the summaries built on top of them, and noticing the distance between the two is the most useful thing a first hour of reading can do.
| Length | 16 amino acids |
| Encoded in | Mitochondrial DNA, 12S rRNA region |
| Class | Mitochondrial-derived peptide |
| Research focus | Metabolic regulation, glucose handling, exercise response |
| Format | Pre-filled peptide pen |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Cell and animal work, early human interest |
| Category | Research use only |
Characteristics of the compound as supplied. No claim attaches to them.
Why it sits alongside NAD+
Both compounds concern how cells manage energy, and researchers interested in one are usually interested in the other. The mechanisms are unrelated, but the questions they are asked about overlap heavily.
The difference is that MOTS-c is a peptide with an identified sequence and origin, while NAD+ is a coenzyme every cell already runs on. Their evidence bases are shaped quite differently as a result.
Sixteen residues is short enough that confirming identity is straightforward, which is one of the few practical advantages of working with a novel compound: whatever the biology turns out to be, the analytical question has a clean answer available today. Our guide to reading a certificate of analysis is where that answer is supposed to appear.
Where MOTS-c research has actually reached
The evidence here has a particular shape: one clear and genuinely interesting original finding, a body of cell and animal work exploring it, and human data that is largely observational. Each of those layers supports a different kind of statement, and the trouble starts when a claim belonging to one layer gets written in the language of another.
The exercise association is the cleanest example of that. Observing that circulating levels of a peptide shift with physical activity is a finding about physiology. It is not a finding about what administering the peptide does, which is a separate experiment and one largely still to be reported.
By association rather than by demonstrated effect, that places the compound in the muscle and performance area of this catalogue. Everything here is supplied under the research use only classification, and this is one of the compounds that shows most clearly why that classification is not a formality.
MOTS-c in the catalogue
A 99% HPLC standard, applied to each production run separately.
Where MOTS-c fits in
Three related articles, chosen for what they add.
About MOTS-c
Straight answers to frequent questions.